{"id":"https://openalex.org/W2172807023","doi":"https://doi.org/10.1016/j.antiviral.2015.10.008","title":"Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries","display_name":"Assessment of the activity of directly acting antivirals and other products against different genotypes of hepatitis C virus prevalent in resource-poor countries","publication_year":2015,"publication_date":"2015-11-22","ids":{"openalex":"https://openalex.org/W2172807023","doi":"https://doi.org/10.1016/j.antiviral.2015.10.008","mag":"2172807023","pmid":"https://pubmed.ncbi.nlm.nih.gov/26593977"},"language":"en","primary_location":{"id":"doi:10.1016/j.antiviral.2015.10.008","doi":"https://doi.org/10.1016/j.antiviral.2015.10.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2015.10.008","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102591699","display_name":"Hayat Muhammad  Khan","orcid":"https://orcid.org/0000-0003-0868-4227","observed_orcids":["https://orcid.org/0000-0003-0868-4227","https://orcid.org/0009-0005-3707-8199"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I929597975","display_name":"National University of Sciences and Technology","ror":"https://ror.org/03w2j5y17","country_code":"PK","type":"education","lineage":["https://openalex.org/I929597975"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE","PK"],"is_corresponding":false,"raw_author_name":"Hayat Khan","raw_affiliation_strings":["KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium; Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan","KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium","Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium; Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I929597975","https://openalex.org/I99464096"]},{"raw_affiliation_string":"KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan","institution_ids":["https://openalex.org/I929597975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056476810","display_name":"Jan Paeshuyse","orcid":"https://orcid.org/0000-0003-2396-354X","observed_orcids":["https://orcid.org/0000-0003-2396-354X"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jan Paeshuyse","raw_affiliation_strings":["KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0003-2396-354X","affiliations":[{"raw_affiliation_string":"KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078623000","display_name":"Sheeba Murad","orcid":"https://orcid.org/0000-0003-0530-5535","observed_orcids":["https://orcid.org/0000-0003-0530-5535"]},"institutions":[{"id":"https://openalex.org/I929597975","display_name":"National University of Sciences and Technology","ror":"https://ror.org/03w2j5y17","country_code":"PK","type":"education","lineage":["https://openalex.org/I929597975"]}],"countries":["PK"],"is_corresponding":false,"raw_author_name":"Sheeba Murad","raw_affiliation_strings":["Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Immunology Research Group, Health Care Biotechnology Department, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, 44000, Islamabad, Pakistan","institution_ids":["https://openalex.org/I929597975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089010495","display_name":"Johan H. Neyts","orcid":"https://orcid.org/0000-0002-0033-7514","observed_orcids":["https://orcid.org/0000-0002-0033-7514"]},"institutions":[{"id":"https://openalex.org/I24156275","display_name":"Rega Institute for Medical Research","ror":"https://ror.org/03w5j8p12","country_code":"BE","type":"facility","lineage":["https://openalex.org/I24156275"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Johan Neyts","raw_affiliation_strings":["KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium. Electronic address: johan.neyts@rega.kuleuven.be","KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-0033-7514","affiliations":[{"raw_affiliation_string":"KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium. Electronic address: johan.neyts@rega.kuleuven.be","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]},{"raw_affiliation_string":"KU Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Leuven, Belgium","institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5089010495"],"corresponding_institution_ids":["https://openalex.org/I24156275","https://openalex.org/I99464096"],"apc_list":{"value":4160,"currency":"USD","value_usd":4160},"apc_paid":null,"fwci":0.1973,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.60031711,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"125","issue":null,"first_page":"43","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12689","display_name":"Silymarin and Mushroom Poisoning","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11495","display_name":"Animal Virus Infections Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hepatitis-c-virus","display_name":"hepatitis C virus","score":0.9990000128746033},{"id":"https://openalex.org/keywords/direct-acting-antivirals","display_name":"direct-acting antivirals","score":0.9010000228881836},{"id":"https://openalex.org/keywords/nitazoxanide","display_name":"nitazoxanide","score":0.8650000095367432},{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/silibinin","display_name":"silibinin","score":0.996999979019165},{"id":"https://openalex.org/keywords/epigallocatechin-gallate","display_name":"epigallocatechin gallate","score":0.7450000047683716},{"id":"https://openalex.org/keywords/green-tea-extract","display_name":"green tea extract","score":0.9779999852180481},{"id":"https://openalex.org/keywords/hcv-genotypes","display_name":"HCV genotypes","score":0.6909999847412109},{"id":"https://openalex.org/keywords/anti-hcv-activity","display_name":"anti-HCV activity","score":0.8100000023841858},{"id":"https://openalex.org/keywords/low-resource-countries","display_name":"resource-poor countries","score":0.8600000143051147},{"id":"https://openalex.org/keywords/expanded-access-program","display_name":"expanded access program","score":0.7419999837875366},{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C2777130413","wikidata":"https://www.wikidata.org/wiki/Q425702","display_name":"Silibinin","level":2,"score":0.773452877998352},{"id":"https://openalex.org/C2777276848","wikidata":"https://www.wikidata.org/wiki/Q2943789","display_name":"Nitazoxanide","level":2,"score":0.648335874080658},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.585239589214325},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48535147309303284},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.4663003981113434},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4518912434577942},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.4274210035800934},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.4069618582725525},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3896617591381073},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.35202556848526},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.30832773447036743},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.21160608530044556}],"mesh":[{"descriptor_ui":"D000077385","descriptor_name":"Silybin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002392","descriptor_name":"Catechin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005503","descriptor_name":"Food Additives","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006526","descriptor_name":"Hepatitis C","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009574","descriptor_name":"Nitro Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014779","descriptor_name":"Virus Replication","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016174","descriptor_name":"Hepacivirus","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/j.antiviral.2015.10.008","doi":"https://doi.org/10.1016/j.antiviral.2015.10.008","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.antiviral.2015.10.008","pdf_url":null,"source":{"id":"https://openalex.org/S137372404","display_name":"Antiviral Research","issn_l":"0166-3542","issn":["0166-3542","1872-9096"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Research","raw_type":"journal-article"},{"id":"pmid:26593977","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26593977","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral research","raw_type":"Comparative Study"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/517284","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26593977","pdf_url":null,"source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Research, vol. 125, Art.No. S0166-3542(15)30009-7, (43-45)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321730","display_name":"Fonds Wetenschappelijk Onderzoek","ror":"https://ror.org/03qtxy027"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1977092515","https://openalex.org/W1979648505","https://openalex.org/W1981385281","https://openalex.org/W1985939675","https://openalex.org/W1996793943","https://openalex.org/W2003939548","https://openalex.org/W2015217687","https://openalex.org/W2035070842","https://openalex.org/W2042063943","https://openalex.org/W2066172848","https://openalex.org/W2068345565","https://openalex.org/W2071476529","https://openalex.org/W2086431073","https://openalex.org/W2086704276","https://openalex.org/W2110660825","https://openalex.org/W2113923090","https://openalex.org/W2114999861","https://openalex.org/W2122523052","https://openalex.org/W2125096046","https://openalex.org/W2138488044","https://openalex.org/W2159094299"],"related_works":["https://openalex.org/W3092630795","https://openalex.org/W2133647046","https://openalex.org/W2954540963","https://openalex.org/W2054465442","https://openalex.org/W4385074652","https://openalex.org/W2149549646","https://openalex.org/W2805738630","https://openalex.org/W2461962230","https://openalex.org/W3172773478","https://openalex.org/W2418854365"],"abstract_inverted_index":null,"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}